Literature DB >> 6800464

Ultrasound-guided fetal intravenous transfusion for severe rhesus haemolytic disease.

J Bang, J E Bock, D Trolle.   

Abstract

Intrauterine, intraperitoneal transfusion is associated with a poor survival rate in fetuses with hydrops and low gestational age. A method of direct fetal intravenous transfusion was used in two fetuses. One fetus with severe rhesus haemolytic disease was given transfusions in the 29th and 30th weeks of gestation, using an ultrasound-guided needle through the hepatic part of the umbilical vein without fetoscopy. In another fetus, an experimental cannulation of the umbilical vein succeeded in the 23rd week of gestation. Ultrasound-guided fetal intravenous transfusion avoids the use of fetoscopy, which has limitations, and may improve the prognosis for rhesus-sensitised fetuses.

Entities:  

Mesh:

Year:  1982        PMID: 6800464      PMCID: PMC1495956          DOI: 10.1136/bmj.284.6313.373

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  4 in total

1.  Umbilical venous flow as indicator of fetal anaemia.

Authors:  P Kirkinen; P Jouppila; S Eik-Nes
Journal:  Lancet       Date:  1981-05-02       Impact factor: 79.321

2.  Direct intravascular fetal blood transfusion by fetoscopy in severe Rhesus isoimmunisation.

Authors:  C H Rodeck; J R Kemp; C A Holman; D N Whitmore; J Karnicki; M A Austin
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

3.  Early caesarean section in rhesus isoimmunisation.

Authors:  J E Bock; G Lykkesfeldt; D Trolle
Journal:  Lancet       Date:  1978-01-28       Impact factor: 79.321

4.  Intrauterine transfusion utilizing ultrasound.

Authors:  R L Berkowitz; J C Hobbins
Journal:  Obstet Gynecol       Date:  1981-01       Impact factor: 7.661

  4 in total
  12 in total

Review 1.  Fetal surgery: a critical review.

Authors:  H Kitagawa; K C Pringle
Journal:  Pediatr Surg Int       Date:  2017-01-05       Impact factor: 1.827

2.  Consequences of fetomaternal haemorrhage after intrauterine transfusion.

Authors:  U Nicolini; N K Kochenour; P Greco; E A Letsky; R D Johnson; M Contreras; C H Rodeck
Journal:  BMJ       Date:  1988-11-26

3.  Changes in fetal acid base status during intravascular transfusion.

Authors:  U Nicolini; J Santolaya; N M Fisk; C Hubinont; N K Kochenour; P Greco; C H Rodeck
Journal:  Arch Dis Child       Date:  1988-07       Impact factor: 3.791

4.  Fetal intracardiac transfusions in patients with severe rhesus isoimmunisation.

Authors:  M Westgren; A Selbing; M Stangenberg
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-26

Review 5.  Intrauterine transfusion with red cells and platelets.

Authors:  K J Moise
Journal:  West J Med       Date:  1993-09

6.  Intrauterine Fetal Blood Transfusion: Descriptive study of the first four years' experience in Oman.

Authors:  Arwa Z Al-Riyami; Mouza Al-Salmani; Sabria N Al-Hashami; Sabah Al-Mahrooqi; Ali Al-Marhoobi; Sumaiya Al-Hinai; Saif Al-Hosni; Sathiya M Panchatcharam; Zainab A Al-Arimi
Journal:  Sultan Qaboos Univ Med J       Date:  2018-04-04

Review 7.  Modern fetal surgery-a historical review of the happenings that shaped modern fetal surgery and its practices.

Authors:  Lauren L Evans; Michael R Harrison
Journal:  Transl Pediatr       Date:  2021-05

8.  The changing pattern of fetal hydrops.

Authors:  D C Wilson; H L Halliday; G McClure; M M Reid
Journal:  Ulster Med J       Date:  1990-10

9.  In utero nanoparticle delivery for site-specific genome editing.

Authors:  Adele S Ricciardi; Raman Bahal; James S Farrelly; Elias Quijano; Anthony H Bianchi; Valerie L Luks; Rachael Putman; Francesc López-Giráldez; Süleyman Coşkun; Eric Song; Yanfeng Liu; Wei-Che Hsieh; Danith H Ly; David H Stitelman; Peter M Glazer; W Mark Saltzman
Journal:  Nat Commun       Date:  2018-06-26       Impact factor: 17.694

10.  The near disappearance of fetal hydrops in relation to current state-of-the-art management of red cell alloimmunization.

Authors:  Carolien Zwiers; Dick Oepkes; Enrico Lopriore; Frans J Klumper; Masja de Haas; Inge L van Kamp
Journal:  Prenat Diagn       Date:  2018-09-27       Impact factor: 3.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.